Oklahoma 2024 Regular Session

Oklahoma House Bill HB1736 Latest Draft

Bill / Enrolled Version Filed 04/19/2023

                            An Act 
ENROLLED HOUSE 
BILL NO. 1736 	By: Townley, Miller, Conley and 
Davis of the House 
 
  and 
 
  Stanley of the Senate 
 
 
 
 
 
An Act relating to step therapy protocol; defining 
terms; requiring health benefit plans to implement a 
new process; providing exceptions to step therapy 
protocol; prescribing required processes; providing 
for certain information or supporting documentation 
not required for submission; providing standard for 
determinations; requiring information be readily 
available on the health benefit pl an's website; 
establishing disposition process fo r requests; 
clarifying applicability of act; providing for 
codification; and providing an effective date. 
 
 
 
SUBJECT: Step therapy protocol 
 
BE IT ENACTED BY THE PEOPLE OF THE STATE O F OKLAHOMA: 
 
SECTION 1.     NEW LAW     A new section of law to be codifie d 
in the Oklahoma Statutes as Section 7330 of Title 63, unless there 
is created a duplication in numberin g, reads as follows: 
 
A. "Health benefit plan" means a plan as defined pursuant to 
Section 6060.4 of Title 3 6 of the Oklahoma Statutes, that provides 
coverage for invasive or noninvasive mechanical ventilation to treat 
chronic respiratory failure consequent to chronic obstructive 
pulmonary disease (CRF -COPD), requiring a step therapy protocol. 
 
B. "Treatment step therap y protocol" means a treatment 
utilization management protocol or program under which a g roup 
health plan or health insurance issuer offerin g group health 
insurance coverage of respiratory care treatments requires a 
participant or beneficiary to tr y an alternative, plan-preferred  ENR. H. B. NO. 1736 	Page 2 
treatment and fail on this treatment before the plan or health 
insurance issuer approves coverage for the non -preferred therapy 
prescribed by the beneficiar y's medical provider. 
 
C. A health benefit plan shall: 
 
1. Implement a clear and transparent process for a pa rticipant 
or beneficiary, or the prescribing health ca re provider on behalf of 
the participant or benefic iary, with CRF-COPD to request an 
exception to such a step therapy protocol, pursuant to subsection B 
of this section; and 
 
2. Where the participant or beneficiary or prescribing health 
care provider's request for an exception to the treatment step 
therapy protocols satisfies the criteria and requirements of 
subsection D of this section, cover the requested treatment in 
accordance with the terms established by the health plan or coverage 
for patient cost-sharing rates or amounts at the time of the 
participant's or beneficiary's enrollment in the health plan or 
health insurance coverage. 
 
D. The circumstances requiring an e xception to a treatment step 
therapy protocol, pursuant to a request und er subsection C of this 
section, are any of the following: 
 
1. Any treatments otherwise required under the protocol have 
not been shown to be as ef fective as other available options in the 
treatment of the disease or condition or the participant or 
beneficiary, when prescribed consistent with clinical indications, 
clinical guidelines, or other peer-reviewed evidence; 
 
2. Delay of proven effective tr eatment would lead to severe or 
irreversible consequences, and the tre atment initially required 
under the protocol is reasonably expected to be less effective  
based upon the documented physical or mental characteristics of the 
participant or beneficiary a nd the known characteristics of such 
treatment; 
 
3. Any treatments otherwise required under the protocol are 
contraindicated for the participant or beneficiary or have caused, 
or are likely to cause, based on clinical, peer -reviewed evidence, 
an adverse reaction or other physical harm to the p articipant or 
beneficiary; 
  ENR. H. B. NO. 1736 	Page 3 
4. Any treatment otherwise required under the prot ocol has 
prevented, will prevent, or is likely to prevent a participant or 
beneficiary from achieving or maintaining reasonable and safe 
functional ability in performing occupati onal responsibilities or 
activities of daily living; or 
 
5. The patient's disease state is classified as life 
threatening. 
 
E. The process required by subsection C of this section shall: 
 
1. Provide the prescribing health care provider or beneficiary 
or designated third-party advocate an opportunity to present such 
provider's clinical rationale and relevant medical information for 
the group health plan or health insurance issuer to evaluate such 
request for exception; 
 
2. Clearly set forth all required info rmation and the specific 
criteria that will be used to determine whether an exception is 
warranted, which may require disclosure of the medical history or 
other health records of the participant or beneficiary demonstrating 
that the participant or benefici ary seeking an exception : 
 
a. has tried other qualifying treatments without success, 
or 
 
b. has received the requested treatment for a clinically 
appropriate amount of time t o establish stability, in 
relation to the condition being treated and guidelines 
given by the prescribing physician . 
 
Other clinical information that may be relevant to conducting 
the exception review may require disclosure. 
 
3. Not require the submission of any information or supporting 
documentation beyond what is strictly necessary to d etermine whether 
any of the circumstances listed in subsection B of this section 
exist. 
 
F.  The health benefit plan shall make information regarding the 
process required under subsection C of this section readily 
available on the Internet website of the gr oup health plan or health 
insurance issuer.  Such information shall include: 
  ENR. H. B. NO. 1736 	Page 4 
1. The requirements for requesting an exception to a treatment 
step therapy protocol pursuant to this section; and 
 
2. Any forms, supporting information, and contact information, 
as appropriate. 
 
G. The process required under paragraph 1 of subsection C of 
this section shall provide for the disposition of requests received 
under such paragraph in accordance with the following: 
 
1. Subject to paragraph 2 of this subsection, not lat er than 
seventy-two (72) hours after receiving an initial exception request, 
the plan or issuer shall respond to the requesting prescriber with 
either a determination of exception eligibility or a reques t for 
additional required information , strictly necessary to make a 
determination of whether the conditions specified in subsection D of 
this section are met.  The plan or issuer shall respon d to the 
requesting provider with a determination of exception eligibility no 
later than seventy-two (72) hours after receipt of the additional 
required information; or 
 
2. In the case of a request under circu mstances in which the 
applicable equipment step therapy protocol may seriously jeopardize 
the life or health of the participant or beneficiary, the plan or 
issuer shall conduct a review of the reque st and respond to the 
requesting prescriber with either a determination or exception 
eligibility or a request for additional required information 
strictly necessary to make a determination of whether the conditions 
specified in subsection D of this section are met, in accordance 
with the following: 
 
a. if the plan or issuer can make a determination of 
exception eligibility without additional information, 
such determination shall be made on an expedited basis 
and no later than one (1) business day after receipt 
of such request, or 
 
b. if the plan or issuer require s additional information 
before making a determin ation of exception 
eligibility, the plan or issuer shall resp ond to the 
requesting provider with a request for such 
information within one (1) business day of the request 
for a determination, and shall res pond with a 
determination of exception eligibility as quickly as 
the condition or disease requires and no later than  ENR. H. B. NO. 1736 	Page 5 
one (1) business day after receipt of the additional 
required information. 
 
H.  This act shall apply with respect to any licen sed provider 
in the State of Oklahoma that provides coverage of a treatment 
pursuant to a policy that meets the definitio n of treatment step 
therapy protocol in subsection B of this section, regardless of 
whether such policy is described by such group he alth plan or health 
insurance coverage as a step therapy protocol. 
 
SECTION 2. This act shall become effective November 1, 2023. 
  ENR. H. B. NO. 1736 	Page 6 
Passed the House of Representatives the 8th day of March, 2023. 
 
 
 
  
 	Presiding Officer of the House 
 	of Representatives 
 
 
 
Passed the Senate the 18 day of April, 2023. 
 
 
 
  
 	Presiding Officer of the Senate 
 
 
OFFICE OF THE GOVERNO R 
Received by the Office of the Governor this ____________________ 
day of ___________________, 20_______, at _______ o'clock _______ M. 
By: _________________________________ 
Approved by the Governor of the State of Oklahoma this _____ ____ 
day of ___________________, 20_______, at _______ o'clock _______ M. 
 
 
 	_________________________________ 
 	Governor of the State of Oklahoma 
 
OFFICE OF THE SECRETARY OF STATE 
Received by the Office of the Secretary of State this __________ 
day of ___________________, 20___ ____, at _______ o'clock _______ M. 
By: _________________________________